Cormedix (CRMD) Receives a Buy From Truist Financial
Earnings Preview: CorMedix to Report Financial Results Pre-market on October 30
$CorMedix(CRMD.US)$ is scheduled to release its financial results pre-market on October 30 ET. Earnings PreviewAnalysts estimate $CorMedix(CRMD.US)$ to post revenue of USD10.84M for 2024Q3, EPS is
CorMedix Inc. Announces New Data at ASN Kidney Week 2024
CORMEDIX INC. ANNOUNCES NEW DATA AT ASN KIDNEY WEEK 2024
CorMedix Inc. to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on October 30, 2024
CorMedix Inc. (CRMD): A Bull Case Theory
CorMedix Is Maintained at Buy by Truist Securities
Cormedix Analyst Ratings
Express News | CorMedix Inc : Truist Securities Raises Target Price to $17 From $12
CorMedix Stock Trends After New Commercial Agreement With Dialysis Operator: Retail Spirit Stays 'Bullish'
JMP Securities Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $19
Cormedix (CRMD) Receives a Buy From JMP Securities
We Think CorMedix (NASDAQ:CRMD) Can Afford To Drive Business Growth
Express News | CorMedix Inc - Enters Supply Contract With Top-Five Mid-Sized Dialysis Operator
Hedge Funds Pile Into Healthcare Stocks Amid Dip, Goldman Sachs Says
CorMedix Inc. (NASDAQ:CRMD): When Will It Breakeven?
CorMedix Inc. Announces New Commercial Agreement To Provide Access To DefenCath For Adult Patients With Kidney Failure Receiving Hemodialysis Through A Central Venous Catheter At More Than 250 Outpatient Dialysis Clinics Located Across The United States
CorMedix Inc. to Present at the Cantor Global Healthcare Conference
CORMEDIX INC. TO PRESENT AT THE CANTOR GLOBAL HEALTHCARE CONFERENCE
Buy Rating on Cormedix Affirmed Amidst DefenCath's Strong Market Entry and Growth Prospects